Further Early Stage Researchers have joined the InPharma network over the summer. We would like the opportunity to welcome them to the project and shortly introduce them all to you.

Lotte Ejskjær (ESR4) has recently started at UCC and her research project focuses on molecular dynamics simulations to predict drug supersaturation (Dosup) in microemulsion formulations

Paul Vrenken (ESR10) is situated at Bayer and will research in silico methods for selecting oral formulations and dosing conditions in early clinical studies